Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
August-2019 Volume 18 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2019 Volume 18 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells

  • Authors:
    • Shiyi Wang
    • Yihong Fan
    • Yi Xu
    • Lu Zhang
    • Lijun Cai
    • Bin Lv
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, Ningbo Hospital of TCM Affiliated to Zhejiang Chinese Medical University, Ningbo, Zhejiang 315000, P.R. China, Department of Gastroenterology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310006, P.R. China
  • Pages: 1315-1322
    |
    Published online on: June 13, 2019
       https://doi.org/10.3892/etm.2019.7670
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Glioblastoma multiforme is the most aggressive primary brain cancer in adults. Therefore, it is important to investigate the mechanisms associated with cell viability and invasion ability of the cells in glioblastoma multiforme. The opposite strand of the glial cell line‑derived neurotrophic factor (GDNF) gene is used to transcribe the cis‑antisense GDNF opposite strand (GDNFOS) gene, which belongs to the long noncoding RNAs. The current study assessed the effects of GDNFOS1 overexpression and interference on GDNF expression, cell viability and invasion ability in U87 and U251 MG glioblastoma cells. Overexpression and interference were performed using constructed lentiviral vectors, including long non‑coding RNA GDNFOS1 overexpression vector, pL‑short hairpin RNA (shRNA)‑GDNFOS1‑9, pL‑shRNA‑GDNFOS1‑49, pL‑shRNA‑GDNFOS1‑248, pL‑shRNA‑GDNFOS1‑9+49, pL‑shRNA‑GDNFOS1‑9+248 and pL‑shRNA‑GDNFOS1‑49+248. Reverse transcription‑quantitative PCR was used to determine the efficiency of interference and overexpression of GDNFOS1 in U87 and U251 MG cells. GDNF protein expression in U87 and U251 MG cells was detected using western blot analysis. In addition, cell viability was detected using a cell counting kit‑8 assay at 24, 48 and 72 h after GDNFOS1 overexpression or interference. A transwell invasion assay was used to detect invasion ability. Different shRNA sequences were tested and the results revealed that a combination (pL‑shRNA‑GDNFOS1‑49+248) was most effective in the knock‑down GDNFOS1. Compared with the control group, GDNF expression in U87 MG cells was significantly increased in the GDNFOS1 overexpression group and decreased in the shRNA‑GDNFOS1‑248 group. U87 MG cell viability was significantly increased in the GDNFOS1 overexpression group at 24, 48 and 72 h compared with the negative control group. The viability of U87 MG cells was decreased in the GDNFOS1 interference group at 72 h when compared with the control group. The relative invasive ability was significantly increased in the GDNFOS1 overexpression group when compared with the negative control group. The invasive ability was significantly decreased in the GDNFOS1 interference group when compared with the negative control group. Similar results were exhibited by the U251 MG cells. Overall, GDNF expression, cell viability and invasion ability of glioblastoma cells significantly increased with GDNFOS1 overexpression and decreased with GDNFOS1 interference.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Bleeker FE, Molenaar RJ and Leenstra S: Recent advances in the molecular understanding of glioblastoma. J Neurooncol. 108:11–27. 2012. View Article : Google Scholar : PubMed/NCBI

2 

Gallego O: Nonsurgical treatment of recurrent glioblastoma. Curr Oncol. 22:e273–e281. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simmons L, Moffet B, Vandlen RA, Simpson LC, et al: GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 266:1062–1064. 1994. View Article : Google Scholar : PubMed/NCBI

4 

Lin LF, Doherty DH, Lile JD, Bektesh S and Collins F: GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1130–1132. 1993. View Article : Google Scholar : PubMed/NCBI

5 

Arenas E, Trupp M, Akerud P and Ibáñez CF: GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron. 15:1465–1473. 1995. View Article : Google Scholar : PubMed/NCBI

6 

Trok K, Hoffer B and Olson L: Glial cell line-derived neurotrophic factor enhances survival and growth of prenatal and postnatal spinal cord transplants. Neuroscience. 71:231–241. 1996. View Article : Google Scholar : PubMed/NCBI

7 

Airaksinen MS and Saarma M: The GDNF family: Signalling, biological functions and therapeutic value. Nat Rev Neurosci. 3:383–394. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Airavaara M, Pletnikova O, Doyle ME, Zhang YE, Troncoso JC and Liu QR: Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease. J Biol Chem. 286:45093–45102. 2011. View Article : Google Scholar : PubMed/NCBI

9 

Shi C, Zhang L and Qin C: Long non-coding RNAs in brain development, synaptic biology, and Alzheimer's disease. Brain Res Bull. 132:160–169. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Ku MC, Wolf SA, Respondek D, Matyash V, Pohlmann A, Waiczies S, Waiczies H, Niendorf T, Synowitz M, Glass R and Kettenmann H: GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis. Acta Neuropathol. 125:609–620. 2013. View Article : Google Scholar : PubMed/NCBI

11 

Liu B, Chen Q, Tian D, Wu L, Dong H, Wang J, Ji B, Zhu X, Cai Q, Wang L and Zhang S: BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma. Brain Res. 1507:115–124. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Feng SY, Dong CG, Wu WK, Wang XJ, Qiao J and Shao JF: Lentiviral expression of anti-microRNAs targeting miR-27a inhibits proliferation and invasiveness of U87 glioma cells. Mol Med Rep. 6:275–281. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Li G, Zhang H, Liu Y, Kong L, Guo Q and Jin F: Effect of temozolomide on livin and caspase-3 in U251 glioma stem cells. Exp Ther Med. 9:744–750. 2015. View Article : Google Scholar : PubMed/NCBI

14 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

15 

Trupp M, Rydén M, Jörnvall H, Funakoshi H, Timmusk T, Arenas E and Ibáñez CF: Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol. 130:137–148. 1995. View Article : Google Scholar : PubMed/NCBI

16 

Williams LR, Inouye G, Cummins V and Pelleymounter MA: Glial cell line-derived neurotrophic factor sustains axotomized basal forebrain cholinergic neurons in vivo: Dose-response comparison to nerve growth factor and brain-derived neurotrophic factor. J Pharmacol Exp Ther. 277:1140–1151. 1996.PubMed/NCBI

17 

Mwangi S, Anitha M, Mallikarjun C, Ding X, Hara M, Parsadanian A, Larsen CP, Thule P, Sitaraman SV, Anania F and Srinivasan S: Glial cell line-derived neurotrophic factor increases beta-cell mass and improves glucose tolerance. Gastroenterology. 134:727–737. 2008. View Article : Google Scholar : PubMed/NCBI

18 

McKeown SJ, Mohsenipour M, Bergner AJ, Young HM and Stamp LA: Exposure to GDNF enhances the ability of enteric neural progenitors to generate an enteric nervous system. Stem Cell Reports. 8:476–488. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Worley DS, Pisano JM, Choi ED, Walus L, Hession CA, Cate RL, Sanicola M and Birren SJ: Developmental regulation of GDNF response and receptor expression in the enteric nervous system. Development. 127:4383–4393. 2000.PubMed/NCBI

20 

Schiltz CA, Benjamin J and Epstein ML: Expression of the GDNF receptors ret and GFRalpha1 in the developing avian enteric nervous system. J Comp Neurol. 414:193–211. 1999. View Article : Google Scholar : PubMed/NCBI

21 

Chalazonitis A, Rothman TP, Chen J and Gershon MD: Age-dependent differences in the effects of GDNF and NT-3 on the development of neurons and glia from neural crest-derived precursors immunoselected from the fetal rat gut: Expression of GFRalpha-1 in vitro and in vivo. Dev Biol. 204:385–406. 1998. View Article : Google Scholar : PubMed/NCBI

22 

Du F, Wang L, Qian W and Liu S: Loss of enteric neurons accompanied by decreased expression of GDNF and PI3K/Akt pathway in diabetic rats. Neurogastroenterol Motil. 21:1229–e114. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Du F and Liu S: Electroacupuncture with high frequency at acupoint ST-36 induces regeneration of lost enteric neurons in diabetic rats via GDNF and PI3K/AKT signal pathway. Am J Physiol Regul Integr Comp Physiol. 309:R109–R118. 2015. View Article : Google Scholar : PubMed/NCBI

24 

Bottner M, Harde J, Barrenschee M, Hellwig I, Vogel I, Ebsen M and Wedel T: GDNF induces synaptic vesicle markers in enteric neurons. Neurosci Res. 77:128–136. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Oh-hashi K, Kaneyama M, Hirata Y and Kiuchi K: ER calcium discharge stimulates GDNF gene expression through MAPK-dependent and -independent pathways in rat C6 glioblastoma cells. Neurosci Lett. 405:100–105. 2006. View Article : Google Scholar : PubMed/NCBI

26 

Suter-Crazzolara C and Unsicker K: GDNF mRNA levels are induced by FGF-2 in rat C6 glioblastoma cells. Brain Res Mol Brain Res. 41:175–182. 1996. View Article : Google Scholar : PubMed/NCBI

27 

Verity AN, Wyatt TL, Lee W, Hajos B, Baecker PA, Eglen RM and Johnson RM: Differential regulation of glial cell line-derived neurotrophic factor (GDNF) expression in human neuroblastoma and glioblastoma cell lines. J Neurosci Res. 55:187–197. 1999. View Article : Google Scholar : PubMed/NCBI

28 

Akella A, Bhattarai S and Dharap A: Long noncoding RNAs in the pathophysiology of ischemic stroke. Neuromolecular Med; 2019, View Article : Google Scholar

29 

Bakhtiarizadeh MR and Salami SA: Identification and expression analysis of long noncoding RNAs in fat-tail of sheep breeds. G3 (Bethesda). 9:1263–1276. 2019.PubMed/NCBI

30 

Zhang Y, Liu XS, Liu QR and Wei L: Genome-wide in silico identification and analysis of cis natural antisense transcripts (cis-NATs) in ten species. Nucleic Acids Res. 34:3465–3475. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Tang CX, Gu YX, Liu XF, Tong SY, Ayanlaja AA, Gao Y, Ji GQ, Xiong Y, Huang LY and Gao DS: Cross-link regulation of precursor N-cadherin and FGFR1 by GDNF increases U251MG cell viability. Oncol Rep. 40:443–453. 2018.PubMed/NCBI

32 

Cui L, Fang L, Mao X, Chang HM, Leung PCK and Ye Y: GDNF-induced downregulation of miR-145-5p enhances human oocyte maturation and cumulus cell viability. J Clin Endocrinol Metab. 103:2510–2521. 2018. View Article : Google Scholar : PubMed/NCBI

33 

Clarkson ED, Zawada WM and Freed CR: GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport. 7:145–149. 1995. View Article : Google Scholar : PubMed/NCBI

34 

McAlhany RE Jr, West JR and Miranda RC: Glial-derived neurotrophic factor (GDNF) prevents ethanol-induced apoptosis and JUN kinase phosphorylation. Brain Res Dev Brain Res. 119:209–216. 2000. View Article : Google Scholar : PubMed/NCBI

35 

Cavel O, Shomron O, Shabtay A, Vital J, Trejo-Leider L, Weizman N, Krelin Y, Fong Y, Wong RJ, Amit M and Gil Z: Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor. Cancer Res. 72:5733–5743. 2012. View Article : Google Scholar : PubMed/NCBI

36 

He S, Chen CH, Chernichenko N, He S, Bakst RL, Barajas F, Deborde S, Allen PJ, Vakiani E, Yu Z and Wong RJ: GFRα1 released by nerves enhances cancer cell perineural invasion through GDNF-RET signaling. Proc Natl Acad Sci USA. 111:E2008–E2017. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Bhakta S, Crocker LM, Chen Y, Hazen M, Schutten MM, Li D, Kuijl C, Ohri R, Zhong F, Poon KA, et al: An Anti-GDNF family receptor alpha 1 (GFRA1) antibody-drug conjugate for the treatment of hormone receptor-positive breast cancer. Mol Cancer Ther. 17:638–649. 2018. View Article : Google Scholar : PubMed/NCBI

38 

Wang Y, Li Z, Zhang H, Jin H, Sun L, Dong H, Xu M, Zhao P, Zhang B, Wang J, et al: HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer. Cancer Biol Ther. 10:376–382. 2010. View Article : Google Scholar : PubMed/NCBI

39 

Gao J, Yu SR, Yuan Y, Zhang LL, Lu JW, Feng JF and Hu SN: MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway. J Cell Physiol. 234:1827–1841. 2019. View Article : Google Scholar : PubMed/NCBI

40 

Wu D, Liu J, Chen J, He H, Ma H and Lv X: miR-449a suppresses tumor growth, migration and invasion in non-small cell lung cancer by targeting a HMGB1-mediated NF-κB signaling pathway. Oncol Res. 27:227–235. 2019. View Article : Google Scholar : PubMed/NCBI

41 

Mansoori B, Mohammadi A, Ghasabi M, Shirjang S, Dehghan R, Montazeri V, Holmskov U, Kazemi T, Duijf P, Gjerstorff M and Baradaran B: miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. J Cell Physiol. 234:9816–9825. 2019. View Article : Google Scholar : PubMed/NCBI

42 

Sano M, Ijichi H, Takahashi R, Miyabayashi K, Fujiwara H, Yamada T, Kato H, Nakatsuka T, Tanaka Y, Tateishi K, et al: Blocking CXCLs-CXCR2 axis in tumor-stromal interactions contributes to survival in a mouse model of pancreatic ductal adenocarcinoma through reduced cell invasion/migration and a shift of immune-inflammatory microenvironment. Oncogenesis. 8:82019. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Wang S, Fan Y, Xu Y, Zhang L, Cai L and Lv B: GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells. Exp Ther Med 18: 1315-1322, 2019.
APA
Wang, S., Fan, Y., Xu, Y., Zhang, L., Cai, L., & Lv, B. (2019). GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells. Experimental and Therapeutic Medicine, 18, 1315-1322. https://doi.org/10.3892/etm.2019.7670
MLA
Wang, S., Fan, Y., Xu, Y., Zhang, L., Cai, L., Lv, B."GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells". Experimental and Therapeutic Medicine 18.2 (2019): 1315-1322.
Chicago
Wang, S., Fan, Y., Xu, Y., Zhang, L., Cai, L., Lv, B."GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells". Experimental and Therapeutic Medicine 18, no. 2 (2019): 1315-1322. https://doi.org/10.3892/etm.2019.7670
Copy and paste a formatted citation
x
Spandidos Publications style
Wang S, Fan Y, Xu Y, Zhang L, Cai L and Lv B: GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells. Exp Ther Med 18: 1315-1322, 2019.
APA
Wang, S., Fan, Y., Xu, Y., Zhang, L., Cai, L., & Lv, B. (2019). GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells. Experimental and Therapeutic Medicine, 18, 1315-1322. https://doi.org/10.3892/etm.2019.7670
MLA
Wang, S., Fan, Y., Xu, Y., Zhang, L., Cai, L., Lv, B."GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells". Experimental and Therapeutic Medicine 18.2 (2019): 1315-1322.
Chicago
Wang, S., Fan, Y., Xu, Y., Zhang, L., Cai, L., Lv, B."GDNFOS1 knockdown decreases the invasion and viability of glioblastoma cells". Experimental and Therapeutic Medicine 18, no. 2 (2019): 1315-1322. https://doi.org/10.3892/etm.2019.7670
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team